Indication
PIN-1
2 clinical trials
2 products
1 drug
Clinical trial
Evaluate the Safety and Immunogenicity of the 9-valent Human Papillomavirus Recombinant Vaccine (Hansenula Polymorpha) in Chinese Male Aged 9-45 Years: A Randomized, Blinded and Placebo-Controlled Phase I StudyStatus: Completed, Estimated PCD: 2023-11-20
Product
PlaceboClinical trial
A Randomized, Double-blinded, Multicenter and Placebo-controlled Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Recombinant Vaccine (Hansenula Polymorpha) in Chinese Males Aged 18-45 YearsStatus: Not yet recruiting, Estimated PCD: 2027-07-30
Drug
Varlilumab